市場調查報告書
商品編碼
1416179
器官保存解決方案市場- 按解決方案(威斯康辛大學、Custodiol HTK、Perfadex、Celsior)、保存類型(靜態冷藏、低溫、常溫)、器官(腎、肝、肺)、最終用戶、全球預測(2023年- )第2032章Organ Preservation Solution Market - By Solution (University of Wisconsin, Custodiol HTK, Perfadex, Celsior), Preservation Type (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidney, Liver, Lungs), End-user, Global Forecast (2023-2032) |
在全球器官捐贈知識不斷成長的推動下,器官保存解決方案市場規模預計從 2023 年到 2032 年將以超過 6.8% 的CAGR成長。
關於器官捐贈重要性的公眾意識活動和教育活動的不斷加強導致自願器官捐贈者的增加。隨著越來越多的人了解器官移植對拯救生命的影響,對有效器官保存解決方案的需求正在激增。此外,領先的組織正在強調研發投資,以引入先進的保存解決方案,以提高器官活力和移植成功率。一些企業也正在規劃和實施策略性舉措,以簡化器官移植流程,進一步促進整個產業的成長。例如,2023年11月,Paragonix Technologies開發了一個全面的供體器官採購、儲存和運輸服務網路。
器官保存溶液產業分為溶液、保存類型、器官、最終用戶和區域。
根據解決方案,由於 perfadex 解決方案在肺移植手術中的廣泛使用,預計 2023 年至 2032 年間,其市場佔有率將以 6.7% 的CAGR獲得顯著成長。 Perfadex 解決方案擁有獨特的成分和促進最佳器官保存的能力,以確保移植期間延長活力。鑑於它們在最大限度地減少缺血再灌注損傷和改善移植後結果方面的有效性,這些解決方案在器官保存領域越來越受到青睞。由於呼吸系統疾病激增,全球肺移植數量不斷增加,將推動該領域的成長。
從最終用戶來看,醫院領域的器官保存解決方案產業在2022 年需求旺盛,預計到2032 年將實現7.3% 的成長率。醫院在器官移植手術中發揮關鍵作用,因為它們需要使用有效的保存解決方案。全球器官移植數量不斷增加,加上對改善移植後結果的日益重視,刺激了對高品質保存解決方案的需求。
此外,醫院對先進器官保存解決方案的投資不斷增加,以增強器官活力、減少缺血再灌注損傷並提高整體移植成功率,將推動該領域的成長。
從地區來看,由於器官衰竭盛行率不斷上升以及對移植選擇的認知不斷增強,亞太器官保存解決方案市場從2023年到2032年的CAGR預計將達到7.5%。 2015年至2022年間,中國報告了約40,200例死者器官捐獻,其中120,100例為主要器官。此外,醫療基礎設施的改善以及政府加強器官捐贈和移植計劃的舉措激增將推動區域市場的擴張。
Organ Preservation Solution Market size is poised to expand at over 6.8% CAGR from 2023 to 2032, driven by the increasing knowledge of organ donation worldwide.
The growing public awareness campaigns and educational initiatives about the importance of organ donation have led to the rise in voluntary organ donors. With more individuals understanding the impacts of organ transplantation on saving lives, the demand for effective organ preservation solutions is surging. Additionally, leading organizations are emphasizing R&D investments to introduce advanced preservation solutions to enhance organ viability and transplantation success. Several businesses are also planning and implementing strategic initiatives to streamline the organ transplantation process, further contributing to the overall industry growth. For instance, in November 2023, Paragonix Technologies developed a comprehensive network of donor organ procurement, storage, and transportation services.
The organ preservation solution industry is segmented into solution, preservation type, organ, end-user, and region.
As per solution, the market share from the perfadex solution segment is projected to gain significant traction at 6.7% CAGR between 2023 and 2032 owing to its widespread use in lung transplantation procedures. Perfadex solutions boast of unique composition and capabilities in facilitating optimal organ preservation for ensuring extended viability during transplantation. Given their effectiveness in minimizing ischemia-reperfusion injuries and improving post-transplant outcomes, these solutions are increasingly preferred in the organ preservation domain. The increasing number of lung transplants across the globe, driven by the jump in rising respiratory disorders will boost the segment growth.
Based on end-user, the organ preservation solution industry from the hospitals segment witnessed high demand in 2022 and is estimated to record 7.3% growth rate through 2032. Hospitals play a pivotal role in organ transplantation procedures as they necessitate the usage of effective preservation solutions. The increasing number of organ transplants across the globe coupled with the growing emphasis on improving post-transplant outcomes is fueling the demand for high-quality preservation solutions.
Furthermore, the rising investments by hospitals on advanced organ preservation solutions to enhance organ viability, reduce ischemia-reperfusion injuries, and improve the overall transplant success rates will boost the segment growth.
Regionally, the Asia Pacific organ preservation solution market is set to exhibit 7.5% CAGR from 2023 to 2032 owing to the rising prevalence of organ failure and the increasing awareness of transplantation options. Between 2015 and 2022, China reported about 40,200 deceased organ donations, of which 120,100 were major organs. Moreover, the improving healthcare infrastructure along with the surge in government initiatives to enhance organ donation and transplantation programs will propel the regional market expansion.